Nanomedicine Market 2019 Global Share, Trends …

§ April 29th, 2019 § Filed under Nano Medicine Comments Off on Nanomedicine Market 2019 Global Share, Trends …

Apr 29, 2019 (Heraldkeeper via COMTEX) -- Nanomedicine Market 2019

This report focuses on the global Nanomedicinestatus, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanomedicine development in United States, Europe and China.

Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period. Potential pipeline of products based on the nanomolecules and associated technologies are anticipated to drive market with potential avenues of growth. Presence of around 40% of products in phase II of clinical development, is anticipated to result in a number of key commercialization over the coming decade influencing revenue generation over the forecast period. The customized treatment options available for eradication of genetic abnormalities also makes this technology a substantial option for precision medicine. Asia Pacific is expected to witness lucrative growth through to 2025 as a result of rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, rise in the number of venture capital investors from developing economies of this region and increasing international research collaborations are anticipated to propel growth in nanotechnology-based healthcare industry.

Request Free Sample Report @

The key players covered in this studyCombimatrix Ablynx Abraxis Bioscience Celgene Mallinckrodt Arrowhead Research GE Healthcare Merck Pfizer Nanosphere Epeius Biotechnologies Cytimmune Sciences Nanospectra Biosciences

Market segment by Type, the product can be split intoQuantum dots Nanoparticles Nanoshells Nanotubes Nanodevices

Market segment by Application, split intoSegmentation encompasses oncology Infectious diseases Cardiology Orthopedics Others

Market segment by Regions/Countries, this report coversUnited States Europe China Japan Southeast Asia India Central & South America

Complete Report Details @

Table of Contents -Analysis of Key Points

1 Report Overview1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Nanomedicine Market Size Growth Rate by Type (2013-2025) 1.4.2 Quantum dots 1.4.3 Nanoparticles 1.4.4 Nanoshells 1.4.5 Nanotubes 1.4.6 Nanodevices 1.5 Market by Application 1.5.1 Global Nanomedicine Market Share by Application (2013-2025) 1.5.2 Segmentation encompasses oncology 1.5.3 Infectious diseases 1.5.4 Cardiology 1.5.5 Orthopedics 1.5.6 Others 1.6 Study Objectives 1.7 Years Considered

2 Global Growth Trends2.1 Nanomedicine Market Size 2.2 Nanomedicine Growth Trends by Regions 2.2.1 Nanomedicine Market Size by Regions (2013-2025) 2.2.2 Nanomedicine Market Share by Regions (2013-2018) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities

3 Market Share by Key Players3.1 Nanomedicine Market Size by Manufacturers 3.1.1 Global Nanomedicine Revenue by Manufacturers (2013-2018) 3.1.2 Global Nanomedicine Revenue Market Share by Manufacturers (2013-2018) 3.1.3 Global Nanomedicine Market Concentration Ratio (CR5 and HHI) 3.2 Nanomedicine Key Players Head office and Area Served 3.3 Key Players Nanomedicine Product/Solution/Service 3.4 Date of Enter into Nanomedicine Market 3.5 Mergers & Acquisitions, Expansion Plans


12 International Players Profiles12.1 Combimatrix12.1.1 Combimatrix Company Details 12.1.2 Company Description and Business Overview 12.1.3 Nanomedicine Introduction 12.1.4 Combimatrix Revenue in Nanomedicine Business (2013-2018) 12.1.5 Combimatrix Recent Development 12.2 Ablynx12.2.1 Ablynx Company Details 12.2.2 Company Description and Business Overview 12.2.3 Nanomedicine Introduction 12.2.4 Ablynx Revenue in Nanomedicine Business (2013-2018) 12.2.5 Ablynx Recent Development 12.3 Abraxis Bioscience12.3.1 Abraxis Bioscience Company Details 12.3.2 Company Description and Business Overview 12.3.3 Nanomedicine Introduction 12.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2013-2018) 12.3.5 Abraxis Bioscience Recent Development 12.4 Celgene12.4.1 Celgene Company Details 12.4.2 Company Description and Business Overview 12.4.3 Nanomedicine Introduction 12.4.4 Celgene Revenue in Nanomedicine Business (2013-2018) 12.4.5 Celgene Recent Development 12.5 Mallinckrodt12.5.1 Mallinckrodt Company Details 12.5.2 Company Description and Business Overview 12.5.3 Nanomedicine Introduction 12.5.4 Mallinckrodt Revenue in Nanomedicine Business (2013-2018) 12.5.5 Mallinckrodt Recent Development 12.6 Arrowhead Research12.6.1 Arrowhead Research Company Details 12.6.2 Company Description and Business Overview 12.6.3 Nanomedicine Introduction 12.6.4 Arrowhead Research Revenue in Nanomedicine Business (2013-2018) 12.6.5 Arrowhead Research Recent Development 12.7 GE Healthcare12.7.1 GE Healthcare Company Details 12.7.2 Company Description and Business Overview 12.7.3 Nanomedicine Introduction 12.7.4 GE Healthcare Revenue in Nanomedicine Business (2013-2018) 12.7.5 GE Healthcare Recent Development 12.8 Merck12.8.1 Merck Company Details 12.8.2 Company Description and Business Overview 12.8.3 Nanomedicine Introduction 12.8.4 Merck Revenue in Nanomedicine Business (2013-2018) 12.8.5 Merck Recent Development 12.9 Pfizer12.9.1 Pfizer Company Details 12.9.2 Company Description and Business Overview 12.9.3 Nanomedicine Introduction 12.9.4 Pfizer Revenue in Nanomedicine Business (2013-2018) 12.9.5 Pfizer Recent Development 12.10 Nanosphere12.10.1 Nanosphere Company Details 12.10.2 Company Description and Business Overview 12.10.3 Nanomedicine Introduction 12.10.4 Nanosphere Revenue in Nanomedicine Business (2013-2018) 12.10.5 Nanosphere Recent Development


CONTACT US:Norah TrentPartner Relations & Marketing Managersales@wiseguyreports.comwww.WiseGuyReports.comPh: +1-646-845-9349 (US)Ph: +44 208 133 9349 (UK)

Read the rest here:
Nanomedicine Market 2019 Global Share, Trends ...

Comments are closed.